CureVac's market cap is currently ―. The company's EPS TTM is $-0.681; its P/E ratio is -9.44; CureVac is scheduled to report earnings on April 13, 2023, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	€ 11.21M	€ 20.15M	€ 24.37M	€ 41.23M	€ 29.34M
Gross Profit	€ -12.87M	€ -22.54M	€ -12.86M	€ -28.79M	€ -85.68M
EBIT	€ -47.10M	€ -56.98M	€ -13.25M	€ -4.24M	€ -141.56M
EBITDA	€ -40.41M	€ -49.40M	€ -4.17M	€ 96.00K	€ -141.56M
Net Income Common Stockholders	€ -47.57M	€ -57.58M	€ -15.09M	€ -1.94M	€ -144.02M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 543.46M	€ 577.17M	€ 662.87M	€ 816.11M	€ 1.07B
Total Assets	€ 910.51M	€ 925.82M	€ 1.03B	€ 1.16B	€ 1.66B
Total Debt	€ 41.26M	€ 40.21M	€ 40.66M	€ 28.89M	€ 56.52M
Net Debt	€ -502.20M	€ -536.97M	€ -622.21M	€ -787.22M	€ -1.01B
Total Liabilities	€ 285.52M	€ 302.62M	€ 351.80M	€ 469.77M	€ 967.83M
Stockholders Equity	€ 624.99M	€ 623.20M	€ 674.86M	€ 688.48M	€ 695.29M
Cash Flow	-
Free Cash Flow	€ -63.76M	€ -92.19M	€ -153.70M	€ -217.67M	-
Operating Cash Flow	€ -35.92M	€ -64.66M	€ -136.51M	€ -183.07M	-
Investing Cash Flow	€ -27.84M	€ -27.53M	€ -17.18M	€ -34.60M	-
Financing Cash Flow	€ 26.46M	€ 3.87M	€ -460.00K	€ -33.52M	-

Currency in EUR

CureVac Earnings and Revenue History

Income Statement >

CureVac Debt to Assets

Balance Sheet >

CureVac Cash Flow

Cash Flow >

CureVac Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing